Evidence map›Paper›PMID 38427950›Full record

ArticlePLoS pathogens2024

Candida albicans translocation through the intestinal epithelial barrier is promoted by fungal zinc acquisition and limited by NFκB-mediated barrier protection.

Jakob L Sprague, Tim B Schille, Stefanie Allert, Verena Trümper, Adrian Lier, Peter Großmann, Emily L Priest, Antzela Tsavou, Gianni Panagiotou, Julian R Naglik and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Fungal Reactive Oxygen Species Secreted byJournal of fungi (Basel, Switzerland) · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. microLife · 2026
    Article
  9. Review
  10. Article
  11. Gut microbes · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. mBio · 2025
    Article
  18. Commensal colonization ofMicrobiology spectrum · 2025
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Jakob L SpragueDepartment of Microbial Pathogenicity Mechanisms, Hans-Knöll-Institute, Jena, Germany.
Tim B SchilleDepartment of Microbial Pathogenicity Mechanisms, Hans-Knöll-Institute, Jena, Germany.
Stefanie AllertDepartment of Microbial Pathogenicity Mechanisms, Hans-Knöll-Institute, Jena, Germany.
Verena TrümperDepartment of Microbial Pathogenicity Mechanisms, Hans-Knöll-Institute, Jena, Germany.
Adrian LierDepartment of Microbial Pathogenicity Mechanisms, Hans-Knöll-Institute, Jena, Germany.
Peter GroßmannDepartment of Microbiome Dynamics, Hans-Knöll-Institute, Jena, Germany.
Emily L PriestCentre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.
Antzela TsavouCentre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.
Gianni PanagiotouCluster of Excellence Balance of the Microverse, Friedrich-Schiller-University Jena, Jena, Germany.
Julian R NaglikCentre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.
Duncan WilsonMedical Research Council, Centre for Medical Mycology at the University of Exeter, Exeter, United Kingdom.
Sascha SchäubleDepartment of Microbiome Dynamics, Hans-Knöll-Institute, Jena, Germany.
Lydia KasperDepartment of Microbial Pathogenicity Mechanisms, Hans-Knöll-Institute, Jena, Germany.
Bernhard HubeDepartment of Microbial Pathogenicity Mechanisms, Hans-Knöll-Institute, Jena, Germany.ORCID 0000-0002-6028-0425
Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) · DEKing's College London · GBUniversity of Exeter · GB

Funding

Host and Fungal Regulation of Type 17 Immunity to Oral CandidiasisR37DE022550 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Sarah L Gaffen · 2017 to 2026
$5.6M
IL-17 Receptor Signaling in the Oral MucosaR01DE022550 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GAFFEN, SARAH L · 2012 to 2016
$2.1M
Medical Research Council MR/V033417/1NIDCR NIH HHS R01 DE022550NIDCR NIH HHS R37 DE022550Wellcome Trust
6 · The paper itself

Abstract

The opportunistic fungal pathogen Candida albicans thrives on human mucosal surfaces as a harmless commensal, but frequently causes infections under certain predisposing conditions. Translocation across the intestinal barrier into the bloodstream by intestine-colonizing C. albicans cells serves as the main source of disseminated candidiasis. However, the host and microbial mechanisms behind this process remain unclear. In this study we identified fungal and host factors specifically involved in infection of intestinal epithelial cells (IECs) using dual-RNA sequencing. Our data suggest that host-cell damage mediated by the peptide toxin candidalysin-encoding gene ECE1 facilitates fungal zinc acquisition. This in turn is crucial for the full virulence potential of C. albicans during infection. IECs in turn exhibit a filamentation- and damage-specific response to C. albicans infection, including NFκB, MAPK, and TNF signaling. NFκB activation by IECs limits candidalysin-mediated host-cell damage and mediates maintenance of the intestinal barrier and cell-cell junctions to further restrict fungal translocation. This is the first study to show that candidalysin-mediated damage is necessary for C. albicans nutrient acquisition during infection and to explain how IECs counteract damage and limit fungal translocation via NFκB-mediated maintenance of the intestinal barrier.

Indexed as

Candida albicansCandidiasisEpithelial CellsHumansIntestinesZincZinc

Identifiers

PMID38427950
PMCPMC10907035
OpenAlexW4392363748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.